INTRODUCTION: Although hyperbaric oxygen therapy (HBO) is broadly used for carbon monoxide (CO) poisoning, its efficacy and practical modalities remain controversial. OBJECTIVES: To assess HBO in patients poisoned with CO. DESIGN: Two prospective randomized trial on two parallel groups. SETTING: Critical Care Unit, Raymond Poincaré Hospital, Garches, France. SUBJECTS:Three hundred eighty-five patients with acute domestic CO poisoning. INTERVENTION: Patients with transient loss of consciousness (trial A, n = 179) were randomized to either 6 h of normobaric oxygen therapy (NBO; arm A0, n = 86) or 4 h of NBO plus one HBO session (arm A1, n = 93). Patients with initial coma (trial B, n = 206) were randomized to either 4 h of NBO plus one HBO session (arm B1, n = 101) or 4 h of NBO plus two 2 HBO sessions (arm B2, n = 105). PRIMARY ENDPOINT: Proportion of patients with complete recovery at 1 month. RESULTS: In trial A, there was no evidence for a difference in 1-month complete recovery rates with and without HBO [58% compared to 61%; unadjusted odds ratio, 0.90 (95% CI, 0.47-1.71)]. In trial B, complete recovery rates were significantly lower with two than with one HBO session [47% compared to 68%; unadjusted odds ratio, 0.42 (CI, 0.23-0.79)]. CONCLUSION: In patients with transient loss of consciousness, there was no evidence of superiority of HBO over NBO. In comatose patients, two HBO sessions were associated with worse outcomes than one HBO session.
RCT Entities:
INTRODUCTION: Although hyperbaric oxygen therapy (HBO) is broadly used for carbon monoxide (CO) poisoning, its efficacy and practical modalities remain controversial. OBJECTIVES: To assess HBO in patients poisoned with CO. DESIGN: Two prospective randomized trial on two parallel groups. SETTING: Critical Care Unit, Raymond Poincaré Hospital, Garches, France. SUBJECTS: Three hundred eighty-five patients with acute domestic CO poisoning. INTERVENTION: Patients with transient loss of consciousness (trial A, n = 179) were randomized to either 6 h of normobaric oxygen therapy (NBO; arm A0, n = 86) or 4 h of NBO plus one HBO session (arm A1, n = 93). Patients with initial coma (trial B, n = 206) were randomized to either 4 h of NBO plus one HBO session (arm B1, n = 101) or 4 h of NBO plus two 2 HBO sessions (arm B2, n = 105). PRIMARY ENDPOINT: Proportion of patients with complete recovery at 1 month. RESULTS: In trial A, there was no evidence for a difference in 1-month complete recovery rates with and without HBO [58% compared to 61%; unadjusted odds ratio, 0.90 (95% CI, 0.47-1.71)]. In trial B, complete recovery rates were significantly lower with two than with one HBO session [47% compared to 68%; unadjusted odds ratio, 0.42 (CI, 0.23-0.79)]. CONCLUSION: In patients with transient loss of consciousness, there was no evidence of superiority of HBO over NBO. In comatosepatients, two HBO sessions were associated with worse outcomes than one HBO session.
Authors: J C Raphael; D Elkharrat; M C Jars-Guincestre; C Chastang; V Chasles; J B Vercken; P Gajdos Journal: Lancet Date: 1989-08-19 Impact factor: 79.321
Authors: Lindell K Weaver; Ramona O Hopkins; Karen J Chan; Susan Churchill; C Gregory Elliott; Terry P Clemmer; James F Orme; Frank O Thomas; Alan H Morris Journal: N Engl J Med Date: 2002-10-03 Impact factor: 91.245
Authors: Jason J Rose; Ling Wang; Qinzi Xu; Charles F McTiernan; Sruti Shiva; Jesus Tejero; Mark T Gladwin Journal: Am J Respir Crit Care Med Date: 2017-03-01 Impact factor: 21.405
Authors: Luca Zazzeron; Chen Liu; Walfre Franco; Akito Nakagawa; William A Farinelli; Donald B Bloch; R Rox Anderson; Warren M Zapol Journal: Am J Respir Crit Care Med Date: 2015-11-15 Impact factor: 21.405